"Pills and pulses": Hybrid therapy for atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 1 SUPPL., 2002, Pages

  Murgatroyd, Francis D ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Drug therapy; Nonpharmacologic treatment

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; DILTIAZEM; DISOPYRAMIDE; GLUCOSE; IBUTILIDE; INSULIN; POTASSIUM; VERAPAMIL;

ANTIARRHYTHMIC ACTIVITY; CARDIOVERSION; CATHETER ABLATION; CLINICAL TRIAL; CONFERENCE PAPER; DEFIBRILLATION; DEVICE; DRUG EFFECT; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; PRIORITY JOURNAL; PULMONARY VEIN; RECURRENT DISEASE; SINUS NODE; SINUS RHYTHM;

EID: 0036152826     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2002.tb01952.x     Document Type: Conference Paper

References (48)

1. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation
2. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment
3. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials
4. Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation
5. Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study
6. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter
7. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
8. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation
9. Spontaneous episodes of atrial fibrillation after implantation of the Metrix atrioverter: Observations on treated and nontreared episodes
10. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation
11. Verapamil reduces tachycardia-induced electrical remodeling of the atria
12. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria?
13. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion
14. The effect of verapamil on atrial remodelling in long-term atrial fibrillation
15. The role of intracellular calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation, a randomised sdudy
16. Hybrid pharmacologic and ablative therapy: A novel and effective approach for the management of atrial fibrillation
17. Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: Electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction
18. Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation
19. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: Observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation
20. Radiofrequency catheter ablation for paroxysmal atrial fibrillation in humans: Elaboration of a procedure based on electrophysiological data
21. Catheter ablation approach on the right side only for paroxysmal atrial fibrillation therapy: Long-term results
22. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
23. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci
24. Electrophysiological break-throughs from the left atrium to the pulmonary veins
25. Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins
26. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation
27. Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs
28. Regional entrainment of atrial fibrillation in man
29. Observations from intraatrial recordings on the termination of electrically induced atrial fibrillation in humans
30. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension
31. Mechanism of flecainide's antiarrhythmic action in experimental atrial fibrillation
32. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness
33. Use of procainamide with rapid atrial pacing for successful conversion of atrial flutter to sinus rhythm
34. The effects of class IA antiarrhythmic drug on the common type of atrial flutter in combination with pacing therapy
35. Effects of disopyramide on cycle length, effective refractory period and excitable gap of atrial flutter, and relation to arrhythmia termination by overdrive pacing
36. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing
37. Prevalence, characteristics, and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: Insights from a study using a new implantable device
38. Efficacy of pacing therapies for treating atrial tachyarrhythmias in patient with biventricular arrhythmia receiving a dual-chamber implantable cardioverter defibrillator
39. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients
40. Permanent atrial resynchronization by synchronous bi-atrial pacing in the preventive treatment of atrial flutter associated with high degree interatrial block
41. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing
42. Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery
43. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation
44. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive
45. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation
46. A new pacing algorithm for overdrive suppression of atrial fibrillation
47. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)